U.S. markets closed

Smith & Nephew plc (SNN)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
24.45+0.57 (+2.39%)
Al cierre: 04:00PM EDT
24.45 -0.00 (-0.02%)
Fuera de horario: 04:00PM EDT

Smith & Nephew plc

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
https://www.smith-nephew.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo18,452

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. Deepak S. Nath Ph.D.CEO & Director4.66MN/D1972
Mr. John Terence RogersCFO & Executive DirectorN/DN/D1969
Mr. Paul ConnollyPresident of Global OperationsN/DN/D1968
Mr. Andrew SwiftVice President of Investor RelationsN/DN/DN/D
Ms. Helen BarracloughGroup General Counsel & Company SecretaryN/DN/D1979
Ms. Alison ParkesChief Compliance Officer & Compliance APACN/DN/D1972
Mr. Joe MetzgerSenior Vice President of Marketing Services & CommunicationsN/DN/DN/D
Mr. Philip G. CowdyChief Corporate Development & Corporate Affairs OfficerN/DN/D1967
Ms. Elga LohlerChief Human Resources OfficerN/DN/D1968
Dr. Vasant Padmanabhan Ph.D.President of Research & Development and Ear, Nose & ThroatN/DN/D1967
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Gestión corporativa

La calificación ISS Governance QuickScore de Smith & Nephew plc a partir del 1 de abril de 2024 es 4. Las puntuaciones principales son Auditoría: 8; Junta: 2; Derechos del accionista: 1; Compensación: 7.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.